
Join to View Full Profile
4383 Medical DrFl 3San Antonio, TX 78229
Phone+1 210-593-5700
Fax+1 210-617-7021
Dr. Beeram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
- SUNY Downstate Health Sciences University/Long Island College HospitalResidency, Internal Medicine, 1997 - 2000
- Osmania Medical College NTR UHSClass of 1994
Certifications & Licensure
- TX State Medical License 2005 - 2027
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 May 01
- Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2005 Sep 01
- Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results fro...Santiago Escrivá-de-Romani, Juan M Cejalvo, Emilio Alba, Jennifer Friedmann, Álvaro Rodríguez-Lescure
The Lancet. Oncology. 2025-06-01 - 1 citationsZanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial.Funda Meric-Bernstam, Sun Young Rha, Erika Hamilton, Yoon-Koo Kang, Diana L Hanna
Nature Communications. 2025-05-08 - Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study.Sara M Tolaney, Komal Jhaveri, Teresa Helsten, Shannon L Puhalla, Alison Conlin
Frontiers in Oncology. 2025-01-01
Press Mentions
- Combinations with Abemaciclib Show Long-Term Disease Control in Advanced Breast CancerOctober 19th, 2016
Professional Memberships
- Member
- American Association for Cancer ResearchMember
Other Languages
- Spanish, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: